Home | About | Contacts| News | Quick Links | Search

 
       

Harvard Medical School Teaching Affiliate

For Patients For Providers Academics Careers Services Locations How to Give  

 

Research Home

News

Academics

Institutional Review Board (IRB)

 
 
 

 

INCIDENCE AND GENETICS OF BREAST CANCER IN AFRICAN IMMIGRANTS

This research effort is investigating whether increased incidence of early-onset breast cancer in African women is caused by a genetic predisposition. An additional focus is an analysis of breast cancer prevalence and breast cancer risk factors among African immigrants in the Greater Boston area.

We are looking for women and men of African descent who may have a personal or family history of breast or ovarian cancer, including native African immigrants, and first generation offspring 18 or older. This research study is approved by the CHA Institutional Review Board (IRB).

Background:
Young African-American women are at particular risk for early-onset breast cancer and for poorer outcomes from breast cancer. Although the literature is scarce, studies have shown that African women diagnosed with breast cancer tend to be younger than their Western counterparts, and the disease is most often advanced to stages III and IV at the time of diagnosis.

Study Details:
Study participants will be invited to the CHA Cambridge hospital campus and will undergo a family history intake, a clinical breast exam (if indicated and wanted), and recommendations for screening as appropriate under normal oncology standards. Genetic counseling and testing will also take place at the CHA Cancer Genetics and Prevention Clinic if appropriate.

In a third step, we plan to obtain blood samples for genetic investigation from those African women and their first degree relatives who qualified for a clinic visit based on the information entered on survey questionnaires. We will also obtain tissue for genetic investigation from those who are subsequently diagnosed with breast cancer.

Please note that clinic visits are reimbursable under most insurance plans. There is no extra charge related to being in the study.

Methods:
We hope to identify families with multiple cases of early-onset breast cancer for genome-wide linkage analysis. Using SNP array analysis, we aim to identify chromosomal regions and eventually susceptibility genes that contribute to the high rate of early-onset breast cancer in Africans.

Conclusion:
By studying this genetically more homogenous group of African immigrants we may identify genetic risk factors that are potentially also relevant for early-onset breast cancer in African-Americans. We also hope to better access immigrant and culturally diverse underserved populations through establishing a new model of community outreach based on interpreters and use of community volunteers working as a team with physicians and nurses who commit to interacting with and within the community.

 

 

Contact Info:

Prudence Lam, MD
617-665-1552
PLam@challiance.org


Study Investigators:

Prudence Lam, MD (PI)
Erin Hofstatter, MD
Alemishket Kidane
Tejpreet Nakai, MD
Denise O'Connor, RN
Eva Patalas, MD
Michael Wertheimer, MD
Gerburg Wulf, MD